General Optical Company | |
1235 S Center Rd, Suite 16, Burton, MI 48509-1700 | |
(810) 744-1950 | |
(810) 744-1515 |
Full Name | General Optical Company |
---|---|
Type | Facility |
Speciality | Eyewear Supplier |
Location | 1235 S Center Rd, Burton, Michigan |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003803990 | NPI | - | NPPES |
0983566 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Primary |
332H00000X | Eyewear Supplier | (* (Not Available)) | Primary |
Provider Name | Scott Moore |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1730177122 PECOS PAC ID: 5193781532 Enrollment ID: I20041207000771 |
News Archive
The thalidomide derivative, lenalidomide, is a "safe" and effective treatment in refractory cutaneous lupus erythematosus patients, although three-quarters of patients experience clinical relapse after the drug is withdrawn, say Spanish researchers.
The Centers for Disease Control and Prevention (CDC), reported yesterday (30th of May 2019) that this year the number of measles cases in the United States has reached 971 – a record number in the last 25 years.
In an Autism Research study of 36 newly employed adults with autism spectrum disorder who were participating in a supported employment program, positive well-being—or a sense of happiness and life satisfaction—was associated with a lower risk of developing depression over 12 months of follow-up.
University of Pittsburgh Cancer Institute (UPCI) researchers have uncovered a technique to halt the growth of cancer cells, a discovery that led them to a potential new anti-cancer therapy.
› Verified 1 days ago
Provider Name | Allison Elizabeth Ezell |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1013390921 PECOS PAC ID: 0648584706 Enrollment ID: I20150803001017 |
News Archive
The thalidomide derivative, lenalidomide, is a "safe" and effective treatment in refractory cutaneous lupus erythematosus patients, although three-quarters of patients experience clinical relapse after the drug is withdrawn, say Spanish researchers.
The Centers for Disease Control and Prevention (CDC), reported yesterday (30th of May 2019) that this year the number of measles cases in the United States has reached 971 – a record number in the last 25 years.
In an Autism Research study of 36 newly employed adults with autism spectrum disorder who were participating in a supported employment program, positive well-being—or a sense of happiness and life satisfaction—was associated with a lower risk of developing depression over 12 months of follow-up.
University of Pittsburgh Cancer Institute (UPCI) researchers have uncovered a technique to halt the growth of cancer cells, a discovery that led them to a potential new anti-cancer therapy.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
General Optical Company 405 Garland St, Davison, MI 48423-1330 Ph: () - | General Optical Company 1235 S Center Rd, Suite 16, Burton, MI 48509-1700 Ph: (810) 744-1950 |
News Archive
The thalidomide derivative, lenalidomide, is a "safe" and effective treatment in refractory cutaneous lupus erythematosus patients, although three-quarters of patients experience clinical relapse after the drug is withdrawn, say Spanish researchers.
The Centers for Disease Control and Prevention (CDC), reported yesterday (30th of May 2019) that this year the number of measles cases in the United States has reached 971 – a record number in the last 25 years.
In an Autism Research study of 36 newly employed adults with autism spectrum disorder who were participating in a supported employment program, positive well-being—or a sense of happiness and life satisfaction—was associated with a lower risk of developing depression over 12 months of follow-up.
University of Pittsburgh Cancer Institute (UPCI) researchers have uncovered a technique to halt the growth of cancer cells, a discovery that led them to a potential new anti-cancer therapy.
› Verified 1 days ago